Anti-Glycan Antibody Engineering
- biolabs-marketing
- Jun 28, 2024
- 1 min read
Antibodies are a class of glycoproteins that the immune system naturally produces. They have defense properties against both internal and external antigens, and they are widely used in medicine for illness prevention, diagnosis, and treatment. The development of hybridoma technology by Köhler and Milstein in 1975 allowed for the mass production of identical monoclonal antibodies. Additionally, a new era in the production and application of antibodies against target antigens of infectious pathogens and malignant diseases has begun with the advancement of recent antibody-production platforms and techniques. In the last ten years, engineered antibodies have emerged as a significant class of novel medications for the treatment of autoimmune disorders and cancer. Therefore, novel engineering techniques and methods are necessary to optimize the antibodies or antibody-related molecules to improve specificity, affinity, functionality and so forth.
Learn more: Anti-Glycan Antibody Engineering
Commenti